Global Clinical Research Leaders

From formulation development through global clinical trials to final approval, Symbio provides specialized experience and expertise in clinical research. Our global studies have helped pave the way to advancements in dermatology, ophthalmology, women’s health and internal medicine since 2002.

SPECIALISTS IN DERMATOLOGY CLINICAL TRIALS

From North America to Europe to Latin America, our global Clinical Research Organization (CRO) team has managed more than 150 dermatology clinical trials, resulting in over 50 FDA approvals. As leading experts in dermatology research, Symbio specializes in many areas of dermatology trials including, but not limited to Acne, Psoriasis, Atopic Dermatitis, Rosacea, Actinic Keratosis, Tinea Pedis, Onychomycosis and more.

Symbio Celebrates 20th Anniversary at AAD Annual Meeting

200

Phase 1-4 Clinical Trials

85000

Subjects

1200

Investigators and Clinical Sites

55

FDA Approvals

Home

A Clinical Research Organization that Exceeds All Expectations

Symbio, LLC is a client-focused, global Clinical Research Organization (CRO) with world-class qualifications in the development of therapeutic drugs. We provide a full suite of industry-leading services to sponsors, including:

  • Project Management – experienced project management team that best suits your needs
  • Data Management – in-house database design and user-friendly electronic data capture
  • Medical Monitoring Services – in-house Medical Monitor offering over 30 years of experience
  • BioStatistics – experienced statisticians with extensive knowledge in clinical programs translating clinical thought into statistical data analysis
  • Site Selection – extensive investigator database
  • Monitoring – in-house monitors with extensive experience
  • Medical Writing – fast turnaround times for protocol development and clinical study reports
  • Subject Recruitment – proactive services to shorten enrollment timelines, track and monitor enrollment

We operate all of the core services of our Clinical Research Organization in-house at offices in both the United States and Europe.

Extensive Experience in Clinical Research

Symbio’s executive leadership team has decades of experience in the clinical development of therapeutic medications. Our experienced personnel strategically manage every aspect of clinical trials. We pride ourselves on providing outstanding service every step of the way, from formulation through to final approval.

In conjunction with our subsidiary, Dow Development Laboratories, LLC, Symbio provides a turnkey CRO solution, which includes the design, development and topical formulation of drug products.

Therapeutic Expertise

Dermatology

  • Acne
  • Psoriasis
  • Atopic Dermatitis
  • Rosacea
  • Actinic Keratosis
  • Tinea Pedis
  • Onychomycosis
  • Wound Healing
  • Seborrheic Keratosis
  • Dermal Fillers
  • Alopecia Areata
  • Basal Cell Carcinomas
  • Common Warts
  • Scar Therapy
  • Hair Regeneration
  • Impetigo
  • Secondarily Infected Skin Wounds
  • Rare Disease

Ophthalmology

  • Allergic Conjunctivitis
  • Dry Eye
  • Glaucoma

Women’s Health

  • Fibrocystic Breast Disease
  • Vaginal/Vulvar Atrophy
  • UTI

Internal Medicine

  • Allergic Rhinitis
  • Osteoarthritis
  • Otitis Externa
  • Ulcers of Lower Extremities
  • Internal Hemorrhoids
  • Insomnia

“The reward for providing great work is being awarded with additional studies and projects. Symbio is here to help Sponsors get studies done – whatever it takes.”


RICHARD PANICO, MBA


President, Symbio, LLC and CEO, Symbio in Europe: SRE GmbH

Symbio Research
2019-02-03T19:11:06+00:00
“The reward for providing great work is being awarded with additional studies and projects. Symbio is here to help Sponsors get studies done – whatever it takes.” RICHARD PANICO, MBA President, Symbio, LLC and CEO, Symbio in Europe: SRE GmbH

“Clinical research is a huge group effort. Our Symbio staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.”


DEBRA DOW, PharmD, MBA


Vice President, Scientific Affairs, Symbio, LLC

Symbio Research
2019-02-03T19:11:54+00:00
“Clinical research is a huge group effort. Our Symbio staff understands that we are all in this together, we all want to be part of something successful and work hard to make that happen.” DEBRA DOW, PharmD, MBA Vice President, Scientific Affairs, Symbio, LLC

“Clinical Research is a complex undertaking. I believe that clarity is one of the most important drivers for success in clinical research, and I am happy to add clarity for successfully navigating through the EU clinical trial landscape.”


VERONIKA KUNERT, BSc


COO, Symbio in Europe: SRE GmbH

Symbio Research
2019-02-03T19:12:31+00:00
“Clinical Research is a complex undertaking. I believe that clarity is one of the most important drivers for success in clinical research, and I am happy to add clarity for successfully navigating through the EU clinical trial landscape.” VERONIKA KUNERT, BSc COO, Symbio in Europe: SRE GmbH
0
0
Symbio Research

Contact Symbio

200

Phase 1-4 Clinical Trials

85000

Subjects

1200

Investigators and Clinical Sites

55

FDA Approvals

News & Events

© 2018–2022 Symbio, LLC | Exceeding Expectations in Clinical Research | Site Map | All Rights Reserved | Privacy Policy.
Designed and developed by Progressive Marketing Group, Inc.